Related Experiment Video
Updated: Sep 9, 2026

08:38
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Published on: August 28, 2013
Transdermal Estradiol for Treating Prostate Cancer: Revisiting Huggins and Hodges' Revolutionary Breakthrough
David J Benjamin1, Arash Rezazadeh Kalebasty2
1Hoag Family Cancer Institute, Newport Beach, CA, USA.
European Urology Oncology
|September 7, 2026
Abstract:
Androgen deprivation therapy remains the cornerstone of treating prostate cancer and is now available in multiple formulations based on several randomized phase 3 trials. The estradiol patch offers numerous potential advantages, including fewer hot flashes, less adverse impact on bone health, and less financial toxicity.
